
Drugs.com – Know More. Be Sure.
Feb 27, 2026 · Search 24,000+ prescription, OTC, and natural medications. Peer-reviewed, clinically sourced drug information for safer, smarter health decisions.
Drugs & Medications A to Z - Drugs.com
A basic overview of each product is provided (including dosages, possible drug interactions, side effects and contraindications) along with safety and/or efficacy ratings.
Drug Classification & Categories | Drugs.com
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
Pill Identifier - Quickly Find and ID your Drugs (with pictures)
Use our Pill Identifier tool to instantly match by imprint, shape, color, drug name, or NDC code. Access over 11,500 drug images, updated daily.
Drug Information for Healthcare Professionals - Drugs.com
Access FDA-approved drug information, including AHFS DI Monographs, clinical pharmacology, and interaction data, tailored for healthcare professionals.
Health, Medical & Pharma News - Updated Daily - Drugs.com
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Drugs.com Sitemap
Sitemap for Drugs.com website, with drug information, natural product information, medical dictionary and health encyclopedia alphabetical browse options
Tirzepatide (Zepbound): Uses, Dosage, Side Effects
Feb 26, 2026 · Does Tirzepatide interact with my other drugs? Enter medications to view a detailed interaction report using our Drug Interaction Checker.
Rosuvastatin: Uses, Dosage, Side Effects, Warnings - Drugs.com
Mar 25, 2025 · The tablet formulation for rosuvastatin was first approved by the US Food and Drug Administration (FDA) in 2003 under the brand name Crestor. Many generic versions of rosuvastatin …
Drug Comparison Tool - Drugs.com
View side-by-side comparisons of medication uses, ratings & reviews, prices, FDA alerts, side effects, drug interactions, approval dates, classification, generic availability and more.